Minwen Zheng1, Yongjie Wu2, Mengqi Wei2, Ying Liu2, Hongliang Zhao2, Jian Li2. 1. Department of Radiology, Xijing Hospital, Fourth Military Medical University, No. 169, West Changle Road, Xi'an, Shaanxi Province 710032, China. Electronic address: zhengmw2007@163.com. 2. Department of Radiology, Xijing Hospital, Fourth Military Medical University, No. 169, West Changle Road, Xi'an, Shaanxi Province 710032, China.
Abstract
RATIONALE AND OBJECTIVES: To assess the impact of low-concentration contrast medium on vascular enhancement, image quality, and radiation dose of coronary computed tomography (CT) angiography (CCTA) by using prospectively electrocardiography (ECG)-triggered high-pitch spiral acquisition with low tube voltage in combination with iterative reconstruction. MATERIALS AND METHODS: One hundred patients (body mass index ≤ 25 kg/m(2), heart rate ≤ 65 beats per minute) were prospectively randomized to two groups, with 50 patients each, which were differed by contrast medium. All patients underwent prospectively ECG-triggered high-pitch spiral acquisition CCTA (2 × 128 × 0.6 mm, 300 mAs). Group A patients received iopromide 370 (370 mg I/mL), were scanned using 100 kVp, and reconstructed with filtered back projection. Group B patients received Iodixanol270 (270 mg I/mL), were scanned using low tube voltage of 80 kVp, and reconstructed with iterative reconstruction techniques (IRT). CT attenuation was measured in coronary artery and other anatomic regions. Image quality score, noise, signal-to-noise ratio (SNR), contrast-to-noise ratio (CNR), and radiation dose were calculated and compared. RESULTS: The iodixanol 270 group showed no significant difference in image quality score (1.61 ± 0.69 vs 1.57 ± 0.66; P > .05), CT attenuation (P > .05), noise (P > .05), SNR (47.89 ± 14.03 vs 44.37 ± 12.79; P > .05), and CNR (42.38 ± 12.67 vs 38.13 ± 11.38; P > .05) in comparison to the iopromide 370 group but at a significantly lower radiation dose (0.26 ± 0.05 vs 0.57 ± 0.10; P < .001), which reflects dose saving of 54.4%. CONCLUSIONS: Combining IRT with high-pitch spiral acquisition mode and low-tube-voltage technique, a low-concentration contrast medium of 270 mg I/mL can still maintain the contrast enhancement in coronary arteries without impairing image quality and significantly lower the radiation dose.
RCT Entities:
RATIONALE AND OBJECTIVES: To assess the impact of low-concentration contrast medium on vascular enhancement, image quality, and radiation dose of coronary computed tomography (CT) angiography (CCTA) by using prospectively electrocardiography (ECG)-triggered high-pitch spiral acquisition with low tube voltage in combination with iterative reconstruction. MATERIALS AND METHODS: One hundred patients (body mass index ≤ 25 kg/m(2), heart rate ≤ 65 beats per minute) were prospectively randomized to two groups, with 50 patients each, which were differed by contrast medium. All patients underwent prospectively ECG-triggered high-pitch spiral acquisition CCTA (2 × 128 × 0.6 mm, 300 mAs). Group A patients received iopromide 370 (370 mg I/mL), were scanned using 100 kVp, and reconstructed with filtered back projection. Group B patients received Iodixanol 270 (270 mg I/mL), were scanned using low tube voltage of 80 kVp, and reconstructed with iterative reconstruction techniques (IRT). CT attenuation was measured in coronary artery and other anatomic regions. Image quality score, noise, signal-to-noise ratio (SNR), contrast-to-noise ratio (CNR), and radiation dose were calculated and compared. RESULTS: The iodixanol 270 group showed no significant difference in image quality score (1.61 ± 0.69 vs 1.57 ± 0.66; P > .05), CT attenuation (P > .05), noise (P > .05), SNR (47.89 ± 14.03 vs 44.37 ± 12.79; P > .05), and CNR (42.38 ± 12.67 vs 38.13 ± 11.38; P > .05) in comparison to the iopromide 370 group but at a significantly lower radiation dose (0.26 ± 0.05 vs 0.57 ± 0.10; P < .001), which reflects dose saving of 54.4%. CONCLUSIONS: Combining IRT with high-pitch spiral acquisition mode and low-tube-voltage technique, a low-concentration contrast medium of 270 mg I/mL can still maintain the contrast enhancement in coronary arteries without impairing image quality and significantly lower the radiation dose.